Terms: = Testicular cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Prognosis
21 results:
1. Patterns of Disease Progression and Outcome of Patients With testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy.
Terbuch A; Posch F; Bauernhofer T; Jost PJ; Partl R; Stranzl-Lawatsch H; Baciarello G; Fizazi K; Giannatempo P; Verzoni E; Sweeney C; Ravi P; Tran B; Basso U; White J; Vincenzi B; Oing C; Cutuli HJ; Dieckmann KP; Gamulin M; Chovanec M; Fankhauser CD; Heidenreich A; Mohamad O; Thibault C; Fischer S; Gillessen S;
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(4):825-832. PubMed ID: 35461737
[TBL] [Abstract] [Full Text] [Related]
2. Somatic-type Malignancies in testicular Germ Cell Tumors: A Clinicopathologic Study of 63 Cases.
Hwang MJ; Hamza A; Zhang M; Tu SM; Pisters LL; Czerniak B; Guo CC
Am J Surg Pathol; 2022 Jan; 46(1):11-17. PubMed ID: 34334690
[TBL] [Abstract] [Full Text] [Related]
3. Disparities in cancer Survival Among Adolescents and Young Adults: A Population-Based Study of 88 000 Patients.
Murphy CC; Lupo PJ; Roth ME; Winick NJ; Pruitt SL
J Natl Cancer Inst; 2021 Aug; 113(8):1074-1083. PubMed ID: 33484568
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor.
Taza F; Chovanec M; Snavely A; Hanna NH; Cary C; Masterson TA; Foster RS; Einhorn LH; Albany C; Adra N
J Clin Oncol; 2020 Apr; 38(12):1338-1345. PubMed ID: 32134699
[TBL] [Abstract] [Full Text] [Related]
5. Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer.
Tu SM; Bilen MA; Hess KR; Broaddus RR; Kopetz S; Wei C; Pagliaro LC; Karam JA; Ward JF; Wood CG; Rao P; Tu ZH; General R; Chen AH; Nieto YL; Yeung SC; Lin SH; Logothetis CJ; Pisters LL
Cancer; 2016 Jun; 122(12):1836-43. PubMed ID: 27018785
[TBL] [Abstract] [Full Text] [Related]
6. [Postchemotherapy residual tumour resection in complex metastatic sites of advanced testicular germ cell tumours].
Paffenholz P; Pfister D; Heidenreich A
Urologe A; 2016 May; 55(5):632-40. PubMed ID: 26820659
[TBL] [Abstract] [Full Text] [Related]
7. Changes in bone mineral density in newly diagnosed testicular cancer patients after anticancer treatment.
Willemse PM; Hamdy NA; de Kam ML; Burggraaf J; Osanto S
J Clin Endocrinol Metab; 2014 Nov; 99(11):4101-8. PubMed ID: 25119312
[TBL] [Abstract] [Full Text] [Related]
8. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
[TBL] [Abstract] [Full Text] [Related]
9. A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974).
Daugaard G; Skoneczna I; Aass N; De Wit R; De Santis M; Dumez H; Marreaud S; Collette L; Lluch JRG; Bokemeyer C; Schmoll HJ
Ann Oncol; 2011 May; 22(5):1054-1061. PubMed ID: 21059637
[TBL] [Abstract] [Full Text] [Related]
10. Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.
Malempati S; Gaynon PS; Sather H; La MK; Stork LC;
J Clin Oncol; 2007 Dec; 25(36):5800-7. PubMed ID: 18089878
[TBL] [Abstract] [Full Text] [Related]
11. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of cancer Genitourinary Tract cancer Cooperative Group and the Medical Research Council.
de Wit R; Roberts JT; Wilkinson PM; de Mulder PH; Mead GM; Fosså SD; Cook P; de Prijck L; Stenning S; Collette L
J Clin Oncol; 2001 Mar; 19(6):1629-40. PubMed ID: 11250991
[TBL] [Abstract] [Full Text] [Related]
12. Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of cancer, Genito-Urinary Group, and the Medical Research Council testicular cancer Working Party, Cambridge, United Kingdom.
Fosså SD; Kaye SB; Mead GM; Cullen M; de Wit R; Bodrogi I; van Groeningen CJ; De Mulder PH; Stenning S; Lallemand E; De Prijck L; Collette L
J Clin Oncol; 1998 Feb; 16(2):716-24. PubMed ID: 9469362
[TBL] [Abstract] [Full Text] [Related]
13. Overt testicular disease at diagnosis is associated with high risk features and a poor prognosis in patients with childhood acute lymphoblastic leukemia.
Gajjar A; Ribeiro RC; Mahmoud HH; Sandlund JT; Liu Q; Furman WL; Santana VM; Crist WM; Rivera GK; Pui CH
Cancer; 1996 Dec; 78(11):2437-42. PubMed ID: 8941016
[TBL] [Abstract] [Full Text] [Related]
14. Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
Rivera GK; Hudson MM; Liu Q; Benaim E; Ribeiro RC; Crist WM; Pui CH
Blood; 1996 Aug; 88(3):831-7. PubMed ID: 8704238
[TBL] [Abstract] [Full Text] [Related]
15. The p53 and mdm-2 genes in human testicular germ-cell tumors.
Riou G; Barrois M; Prost S; Terrier MJ; Theodore C; Levine AJ
Mol Carcinog; 1995 Mar; 12(3):124-31. PubMed ID: 7893365
[TBL] [Abstract] [Full Text] [Related]
16. Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile.
Fields KK; Elfenbein GJ; Lazarus HM; Cooper BW; Perkins JB; Creger RJ; Ballester OF; Hiemenz JH; Janssen WE; Zorsky PE
J Clin Oncol; 1995 Feb; 13(2):323-32. PubMed ID: 7844593
[TBL] [Abstract] [Full Text] [Related]
17. Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial.
Loehrer PJ; Johnson D; Elson P; Einhorn LH; Trump D
J Clin Oncol; 1995 Feb; 13(2):470-6. PubMed ID: 7531223
[TBL] [Abstract] [Full Text] [Related]
18. Childhood non-Hodgkin's lymphoma involving the testis: clinical features and treatment outcome.
Kellie SJ; Pui CH; Murphy SB
J Clin Oncol; 1989 Aug; 7(8):1066-70. PubMed ID: 2666589
[TBL] [Abstract] [Full Text] [Related]
19. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of host immunocompetence in urologic cancer patients.
Catalona WJ; Smolev JK; Harty JI
J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
[TBL] [Abstract] [Full Text] [Related]
[Next]